Annual Cash & Cash Equivalents
$178.80 M
-$105.67 M-37.15%
31 March 2024
Summary:
Haemonetics annual cash & cash equivalents is currently $178.80 million, with the most recent change of -$105.67 million (-37.15%) on 31 March 2024. During the last 3 years, it has fallen by -$13.51 million (-7.02%). HAE annual cash & cash equivalents is now -37.15% below its all-time high of $284.47 million, reached on 01 March 2023.HAE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$299.28 M
-$45.15 M-13.11%
28 September 2024
Summary:
Haemonetics quarterly cash and cash equivalents is currently $299.28 million, with the most recent change of -$45.15 million (-13.11%) on 28 September 2024. Over the past year, it has dropped by -$51.72 million (-14.74%). HAE quarterly cash and cash equivalents is now -14.74% below its all-time high of $351.00 million, reached on 30 September 2023.HAE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.1% | -14.7% |
| 3 y3 years | -7.0% | +26.4% |
| 5 y5 years | +5.6% | +167.2% |
HAE Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.1% | at low | -14.7% | +67.4% |
| 5 y | 5 years | -37.1% | +30.2% | -14.7% | +167.2% |
| alltime | all time | -37.1% | +6065.5% | -14.7% | >+9999.0% |
Haemonetics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $299.28 M(-13.1%) |
| June 2024 | - | $344.43 M(+92.6%) |
| Mar 2024 | $178.80 M(-37.1%) | - |
| Mar 2024 | - | $178.80 M(-7.8%) |
| Dec 2023 | - | $193.98 M(-44.7%) |
| Sept 2023 | - | $351.00 M(+22.8%) |
| June 2023 | - | $285.72 M(+0.4%) |
| Mar 2023 | $284.47 M(+9.6%) | $284.47 M(+27.0%) |
| Dec 2022 | - | $224.00 M(-7.1%) |
| Sept 2022 | - | $241.20 M(+12.2%) |
| June 2022 | - | $214.95 M(-17.2%) |
| Mar 2022 | $259.50 M(+34.9%) | $259.50 M(+9.5%) |
| Dec 2021 | - | $236.88 M(+23.1%) |
| Sept 2021 | - | $192.42 M(+10.9%) |
| June 2021 | - | $173.46 M(-9.8%) |
| Mar 2021 | $192.31 M(+40.1%) | $192.31 M(+1.7%) |
| Dec 2020 | - | $189.00 M(-32.3%) |
| Sept 2020 | - | $279.17 M(+1.2%) |
| June 2020 | - | $275.73 M(+100.8%) |
| Mar 2020 | $137.31 M(-18.9%) | $137.31 M(+8.6%) |
| Dec 2019 | - | $126.42 M(+12.8%) |
| Sept 2019 | - | $112.03 M(-41.1%) |
| June 2019 | - | $190.23 M(+12.3%) |
| Mar 2019 | $169.35 M(-6.0%) | $169.35 M(+9.3%) |
| Dec 2018 | - | $154.87 M(-22.5%) |
| Sept 2018 | - | $199.76 M(+4.0%) |
| June 2018 | - | $192.11 M(+6.6%) |
| Mar 2018 | $180.17 M(+29.1%) | $180.17 M(-28.4%) |
| Dec 2017 | - | $251.59 M(+23.6%) |
| Sept 2017 | - | $203.62 M(+18.6%) |
| June 2017 | - | $171.74 M(+23.1%) |
| Mar 2017 | $139.56 M(+21.2%) | $139.56 M(+7.7%) |
| Dec 2016 | - | $129.64 M(-6.6%) |
| Sept 2016 | - | $138.87 M(+17.4%) |
| June 2016 | - | $118.25 M(+2.7%) |
| Mar 2016 | $115.12 M(-28.3%) | $115.12 M(+9.5%) |
| Dec 2015 | - | $105.17 M(+4.9%) |
| Sept 2015 | - | $100.25 M(-10.7%) |
| June 2015 | - | $112.20 M(-30.2%) |
| Mar 2015 | $160.66 M(-16.5%) | $160.66 M(+28.3%) |
| Dec 2014 | - | $125.20 M(-3.7%) |
| Sept 2014 | - | $129.97 M(-7.1%) |
| June 2014 | - | $139.94 M(-27.3%) |
| Mar 2014 | $192.47 M(+7.5%) | $192.47 M(+8.2%) |
| Dec 2013 | - | $177.85 M(+11.7%) |
| Sept 2013 | - | $159.15 M(-4.3%) |
| June 2013 | - | $166.33 M(-7.1%) |
| Mar 2013 | $179.12 M(-21.7%) | $179.12 M(-7.3%) |
| Dec 2012 | - | $193.18 M(+3.3%) |
| Sept 2012 | - | $187.05 M(-20.8%) |
| June 2012 | - | $236.05 M(+3.1%) |
| Mar 2012 | $228.86 M(+16.3%) | $228.86 M(+11.4%) |
| Dec 2011 | - | $205.37 M(+12.0%) |
| Sept 2011 | - | $183.42 M(-15.4%) |
| June 2011 | - | $216.89 M(+10.3%) |
| Mar 2011 | $196.71 M(+39.0%) | $196.71 M(+16.0%) |
| Dec 2010 | - | $169.54 M(+47.4%) |
| Sept 2010 | - | $115.05 M(+37.8%) |
| June 2010 | - | $83.47 M(-41.0%) |
| Mar 2010 | $141.56 M(-9.7%) | $141.56 M(-16.2%) |
| Dec 2009 | - | $168.99 M(-5.2%) |
| Sept 2009 | - | $178.32 M(+2.6%) |
| June 2009 | - | $173.82 M(+10.9%) |
| Mar 2009 | $156.72 M(+17.3%) | $156.72 M(+25.1%) |
| Dec 2008 | - | $125.33 M(+12.6%) |
| Sept 2008 | - | $111.33 M(-7.4%) |
| June 2008 | - | $120.29 M(-9.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | $133.55 M(-41.7%) | $133.55 M(+14.3%) |
| Dec 2007 | - | $116.86 M(-24.6%) |
| Sept 2007 | - | $154.98 M(-28.3%) |
| June 2007 | - | $216.06 M(-5.7%) |
| Mar 2007 | $229.23 M(-8.6%) | $229.23 M(+0.7%) |
| Dec 2006 | - | $227.71 M(-6.0%) |
| Sept 2006 | - | $242.20 M(-6.9%) |
| June 2006 | - | $260.03 M(+3.7%) |
| Mar 2006 | $250.67 M(+34.9%) | $250.67 M(+9.3%) |
| Dec 2005 | - | $229.35 M(+9.2%) |
| Sept 2005 | - | $209.98 M(+6.0%) |
| June 2005 | - | $198.07 M(+6.6%) |
| Mar 2005 | $185.81 M(+133.8%) | $185.81 M(+15.9%) |
| Dec 2004 | - | $160.28 M(+11.4%) |
| Sept 2004 | - | $143.83 M(+10.3%) |
| June 2004 | - | $130.36 M(+64.0%) |
| Mar 2004 | $79.47 M(+59.3%) | $79.47 M(-18.2%) |
| Dec 2003 | - | $97.18 M(+45.5%) |
| Sept 2003 | - | $66.77 M(+33.0%) |
| June 2003 | - | $50.19 M(+0.6%) |
| Mar 2003 | $49.88 M(+42.9%) | $49.88 M(+0.4%) |
| Dec 2002 | - | $49.67 M(+13.9%) |
| Sept 2002 | - | $43.62 M(+3.8%) |
| June 2002 | - | $42.01 M(+20.3%) |
| Mar 2002 | $34.91 M(-15.8%) | $34.91 M(-34.0%) |
| Dec 2001 | - | $52.90 M(-8.6%) |
| Sept 2001 | - | $57.85 M(+41.2%) |
| June 2001 | - | $40.96 M(-1.2%) |
| Mar 2001 | $41.44 M(+59.9%) | $41.44 M(-30.0%) |
| Dec 2000 | - | $59.21 M(+53.3%) |
| Sept 2000 | - | $38.62 M(-26.0%) |
| June 2000 | - | $52.20 M(+101.4%) |
| Mar 2000 | $25.91 M(-54.0%) | $25.91 M(-44.3%) |
| Dec 1999 | - | $46.50 M(-17.3%) |
| Sept 1999 | - | $56.20 M(+5.4%) |
| June 1999 | - | $53.30 M(-5.3%) |
| Mar 1999 | $56.30 M(+158.3%) | $56.30 M(+33.1%) |
| Dec 1998 | - | $42.30 M(+13.7%) |
| Sept 1998 | - | $37.20 M(+53.1%) |
| June 1998 | - | $24.30 M(+11.5%) |
| Mar 1998 | $21.80 M(+162.7%) | $21.80 M(+198.6%) |
| Dec 1997 | - | $7.30 M(+10.6%) |
| Sept 1997 | - | $6.60 M(+17.9%) |
| June 1997 | - | $5.60 M(-32.5%) |
| Mar 1997 | $8.30 M(-38.1%) | $8.30 M(-50.0%) |
| Dec 1996 | - | $16.60 M(+25.8%) |
| Sept 1996 | - | $13.20 M(+21.1%) |
| June 1996 | - | $10.90 M(-18.7%) |
| Mar 1996 | $13.40 M(+219.0%) | $13.40 M(-3.6%) |
| Dec 1995 | - | $13.90 M(+65.5%) |
| Sept 1995 | - | $8.40 M(+127.0%) |
| June 1995 | - | $3.70 M(-11.9%) |
| Mar 1995 | $4.20 M(-74.1%) | $4.20 M(+13.5%) |
| Dec 1994 | - | $3.70 M(-56.0%) |
| Sept 1994 | - | $8.40 M(+33.3%) |
| June 1994 | - | $6.30 M(-61.1%) |
| Mar 1994 | $16.20 M(+57.3%) | $16.20 M(+17.4%) |
| Dec 1993 | - | $13.80 M(+34.0%) |
| Sept 1993 | - | $10.30 M(+134.1%) |
| June 1993 | - | $4.40 M(-57.3%) |
| Mar 1993 | $10.30 M(+255.2%) | $10.30 M(+37.3%) |
| Dec 1992 | - | $7.50 M(+240.9%) |
| Sept 1992 | - | $2.20 M(+144.4%) |
| June 1992 | - | $900.00 K(-69.0%) |
| Mar 1992 | $2.90 M | $2.90 M(+866.7%) |
| Dec 1991 | - | $300.00 K(-57.1%) |
| Sept 1991 | - | $700.00 K(-41.7%) |
| June 1991 | - | $1.20 M |
FAQ
- What is Haemonetics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Haemonetics?
- What is Haemonetics annual cash & cash equivalents year-on-year change?
- What is Haemonetics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Haemonetics?
- What is Haemonetics quarterly cash and cash equivalents year-on-year change?
What is Haemonetics annual cash & cash equivalents?
The current annual cash & cash equivalents of HAE is $178.80 M
What is the all time high annual cash & cash equivalents for Haemonetics?
Haemonetics all-time high annual cash & cash equivalents is $284.47 M
What is Haemonetics annual cash & cash equivalents year-on-year change?
Over the past year, HAE annual cash & cash equivalents has changed by -$105.67 M (-37.15%)
What is Haemonetics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HAE is $299.28 M
What is the all time high quarterly cash and cash equivalents for Haemonetics?
Haemonetics all-time high quarterly cash and cash equivalents is $351.00 M
What is Haemonetics quarterly cash and cash equivalents year-on-year change?
Over the past year, HAE quarterly cash and cash equivalents has changed by -$51.72 M (-14.74%)